Aug. 10 at 6:33 PM
$PFE remains a major global pharmaceutical company with a diversified portfolio and extensive R&D operations. AERT reported Q1 FY2027 net income of
$2.2M compared with
$1.7M a year earlier, extending its profitability momentum.